Department of Integrative Genomics, Tohoku Medical Megabank Organization, 2-1 Seiryo- machi, Aoba-ku, Sendai, 980-8573, Miyagi, Japan.
Department of Ophthalmology, Tohoku University Graduate School of Medicine, 1-1 Seiryo- machi, Aoba-ku, Sendai, 980-8574, Miyagi, Japan.
Jpn J Ophthalmol. 2024 Nov;68(6):688-701. doi: 10.1007/s10384-024-01103-0. Epub 2024 Aug 19.
To explore the frequency and positions of genetic mutations in CYP1B1 and FOXC1 in a Japanese population.
Molecular genetic analysis.
Genomic DNA was extracted from 31 Japanese patients with childhood glaucoma (CG) from 29 families. We examined the CYP1B, FOXC1, and MYOC genes using Sanger sequencing and whole-exome sequencing (WES).
For CYP1B1, we identified 9 families that harbored novel mutations, p.A202T, p.D274E, p.Q340*, and p.V420G; the remaining mutations had been previously reported. When mapped to the CYP1B1 protein structure, all mutations appeared to influence the enzymatic activity of CYP1B1 by provoking structural deformity. Five patients were homozygotes or compound heterozygotes, supporting the recessive inheritance of the CYP1B1 mutations in CG. In contrast, four patients were heterozygous for the CYP1B1 mutation, suggesting the presence of regulatory region mutations or strong modifiers. For the FOXC1 gene, we identified 3 novel mutations, p.Q23fs, p.Q70R, and p.E163*, all of which were identified in a heterozygous state. No mutation was found in the MYOC gene in these CG patients. All individuals with CYP1B1 and FOXC1 mutations were severely affected by early-onset CG. In the CYP1B1-, FOXC1-, and MYOC-negative families, we also searched for variants in the other candidate genes reported for CG through WES, but could not find any mutations in these genes.
Our analyses of 29 CG families revealed 9 families with point mutations in the CYP1B1 gene, and four of those patients appeared to be heterozygotes, suggesting the presence of complex pathogenic mechanisms. FOXC1 appears to be another major causal gene of CG, indicating that panel sequencing of CYP1B1 and FOXC1 will be useful for diagnosis of CG in Japanese individuals.
探讨 CYP1B1 和 FOXC1 基因在日本人群中的突变频率和位置。
分子遗传学分析。
从 29 个家族的 31 名日本儿童青光眼(CG)患者中提取基因组 DNA。我们使用 Sanger 测序和全外显子组测序(WES)对 CYP1B、FOXC1 和 MYOC 基因进行了检测。
对于 CYP1B1,我们发现了 9 个家族携带有新的突变,p.A202T、p.D274E、p.Q340和 p.V420G;其余的突变之前已经有报道。当映射到 CYP1B1 蛋白质结构时,所有的突变似乎都通过引起结构变形来影响 CYP1B1 的酶活性。5 名患者为纯合子或复合杂合子,支持 CYP1B1 突变在 CG 中的隐性遗传。相比之下,4 名患者为 CYP1B1 突变的杂合子,提示存在调节区突变或强修饰物。对于 FOXC1 基因,我们发现了 3 个新的突变,p.Q23fs、p.Q70R 和 p.E163,均为杂合状态。在这些 CG 患者中,没有发现 MYOC 基因的突变。所有 CYP1B1 和 FOXC1 突变的个体均患有早发性 CG,病情严重。在 CYP1B1、FOXC1 和 MYOC 阴性的家族中,我们还通过 WES 搜索了其他报道的 CG 候选基因中的变异,但在这些基因中没有发现任何突变。
我们对 29 个 CG 家族的分析显示,9 个家族的 CYP1B1 基因存在点突变,其中 4 名患者似乎为杂合子,提示存在复杂的致病机制。FOXC1 似乎是 CG 的另一个主要致病基因,表明 CYP1B1 和 FOXC1 的基因测序将有助于日本人群 CG 的诊断。